192 related articles for article (PubMed ID: 27410906)
21. Preliminary results of two novel devices for epiphysiodesis in the reduction of excessive predicted final height in tall stature.
Laufer A; Toporowski G; Gosheger G; von der Heiden A; Rölfing JD; Frommer A; Rachbauer A; Antfang C; Rödl R; Vogt B
J Orthop Traumatol; 2022 Sep; 23(1):46. PubMed ID: 36114882
[TBL] [Abstract][Full Text] [Related]
22. Body composition, fasting leptin, and sex steroid administration determine GH sensitivity in peripubertal short children.
Coutant R; Boux de Casson F; Rouleau S; Douay O; Mathieu E; Audran M; Limal JM
J Clin Endocrinol Metab; 2001 Dec; 86(12):5805-12. PubMed ID: 11739442
[TBL] [Abstract][Full Text] [Related]
23. Treatment of tall stature in boys with somatostatin analogue 201-995: effect on final height.
Noordam C; van Daalen S; Otten BJ
Eur J Endocrinol; 2006 Feb; 154(2):253-7. PubMed ID: 16452538
[TBL] [Abstract][Full Text] [Related]
24. Oestrogen treatment for tall stature in girls: estimating the effect on height and the error in height prediction.
Venn A; Hosmer T; Hosmer D; Bruinsma F; Jones P; Lumley J; Pyett P; Rayner JA; Werther G
Clin Endocrinol (Oxf); 2008 Jun; 68(6):926-9. PubMed ID: 18031324
[TBL] [Abstract][Full Text] [Related]
25. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
[TBL] [Abstract][Full Text] [Related]
26. Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents.
Coutant R; de Casson FB; Rouleau S; Douay O; Mathieu E; Gatelais F; Bouhours-Nouet N; Voinot C; Audran M; Limal JM
J Clin Endocrinol Metab; 2004 Dec; 89(12):6185-92. PubMed ID: 15579776
[TBL] [Abstract][Full Text] [Related]
27. Oestrogen treatment of constitutional tall stature in girls: is there a risk of thrombosis or bleeding?
Rask O; Nilsson KO; Berntorp E
Acta Paediatr; 2008 Mar; 97(3):342-7. PubMed ID: 18298783
[TBL] [Abstract][Full Text] [Related]
28. Adult height in constitutionally tall stature: accuracy of five different height prediction methods.
Joss EE; Temperli R; Mullis PE
Arch Dis Child; 1992 Nov; 67(11):1357-62. PubMed ID: 1471886
[TBL] [Abstract][Full Text] [Related]
29. Estrogen-mediated Height Control in Girls with Marfan Syndrome.
Lee DY; Hyun HS; Huh R; Jin DK; Kim DK; Yoon BK; Choi D
J Korean Med Sci; 2016 Feb; 31(2):275-9. PubMed ID: 26839483
[TBL] [Abstract][Full Text] [Related]
30. The effect of oestrogen treatment on body proportions in constitutionally tall girls.
Brinkers JM; Lamoré PJ; Gevers EF; Boersma B; Wit JM
Eur J Pediatr; 1994 Apr; 153(4):237-40. PubMed ID: 8194553
[TBL] [Abstract][Full Text] [Related]
31. The Evaluation and Management of Tall Stature.
Hannema SE; Sävendahl L
Horm Res Paediatr; 2016; 85(5):347-52. PubMed ID: 26845047
[TBL] [Abstract][Full Text] [Related]
32. The pattern of growth in children with constitutional tall stature from birth to age 9 years. A longitudinal study.
Dickerman Z; Loewinger J; Laron Z
Acta Paediatr Scand; 1984 Jul; 73(4):530-6. PubMed ID: 6464741
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of insulin-like growth factor (IGF) and IGF binding protein in constitutionally tall children and adolescents.
Gourmelen M; Le Bouc Y; Girard F; Binoux M
J Clin Endocrinol Metab; 1984 Dec; 59(6):1197-203. PubMed ID: 6208211
[TBL] [Abstract][Full Text] [Related]
34. Analysis of growth hormone receptor gene expression in tall and short stature children.
Pagani S; Radetti G; Meazza C; Bozzola M
J Pediatr Endocrinol Metab; 2017 Apr; 30(4):427-430. PubMed ID: 28301320
[TBL] [Abstract][Full Text] [Related]
35. Effect of the long-acting somatostatin analogue SMS 201-995 on growth rate and reduction of predicted adult height in ten tall adolescents.
Tauber MT; Tauber JP; Vigoni F; Harris AG; Rochicchioli P
Acta Paediatr Scand; 1990 Feb; 79(2):176-81. PubMed ID: 2321479
[TBL] [Abstract][Full Text] [Related]
36. The medicalisation of 'tall' girls: A discourse analysis of medical literature on the use of synthetic oestrogen to reduce female height.
Rayner JA; Pyett P; Astbury J
Soc Sci Med; 2010 Sep; 71(6):1076-83. PubMed ID: 20678835
[TBL] [Abstract][Full Text] [Related]
37. Treatment of girls with excessive height prediction. Follow-up of forty girls treated with intramuscular estradiol and progesterone.
Andersen H; Jacobsen BB; Kastrup KW; Krabbe S; Peitersen B; Petersen KE; Thamdrup E; Wichmann R
Acta Paediatr Scand; 1980 May; 69(3):293-7. PubMed ID: 7376855
[TBL] [Abstract][Full Text] [Related]
38. Hormonal changes during the first year of oestrogen treatment in constitutionally tall girls.
Wajs-Kuto E; De Beeck LO; Rooman RP; Caju MV
Eur J Endocrinol; 1999 Dec; 141(6):579-84. PubMed ID: 10601959
[TBL] [Abstract][Full Text] [Related]
39. Salutary effects of combining early very low-dose systemic estradiol with growth hormone therapy in girls with Turner syndrome.
Rosenfield RL; Devine N; Hunold JJ; Mauras N; Moshang T; Root AW
J Clin Endocrinol Metab; 2005 Dec; 90(12):6424-30. PubMed ID: 16189255
[TBL] [Abstract][Full Text] [Related]
40. Estrogen treatment in tall girls.
Kuhn N; Blunck W; Stahnke N; Wiebel J; Willig RP
Acta Paediatr Scand; 1977 Mar; 66(2):161-7. PubMed ID: 842338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
